October 2023 FDA Recall Esomeprazole Magnesium by Glenmark Pharmaceuticals Inc., Usa
D-0112-2024 - Failed Impurities/Degradation Specifications

This Class III drug recall was voluntarily initiated by Glenmark Pharmaceuticals Inc., Usa on October 23, 2023 for the product Esomeprazole Magnesium. The FDA reported the reason for recall as failed impurities/degradation specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0112-2024

Reason for Recall
Failed Impurities/Degradation Specifications:Out of Specification result reported for the test of organic impurities for the drug product,at the 18 month time point in long term stability study (25¿C/60% RH).
Initiated
10-23-2023
Reported
11-29-2023
Quantity
8,448 30-count bottles, 168 1000-count bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Glenmark Pharmaceuticals Inc., USA
Nationwide in the USA
Esomeprazole Magnesium Delayed-Release Capsules, USP 20mg, Packaged as (a) 30-count bottle, NDC 68462-390-30; (b) 1000-count Bottle, NDC 68462-390-10: RX Only, Manufactured for: Glenmark, Pharmaceuticals Inc., USA, Mahwah, NJ 07430, Product of India,

Batch or Lot Expiration Information

Lot# 17220002, Exp Date 11/30/2023